The most common Hims complaints cluster around three things: an under-disclosed membership fee, difficulty cancelling or getting refunds, and (separately) a 2025-2026 regulatory dispute over compounded semaglutide marketing that led Hims to discontinue those products.
Luma Health's semaglutide ($197/month) and tirzepatide ($297/month) are priced as one flat number with no separate membership fee.
Hims & Hers is a large, established telehealth company, and its weight-loss program has drawn a specific pattern of complaints worth understanding before enrolling — both about the platform's billing practices and about a significant regulatory episode involving its compounded medication marketing.
The Membership Fee Disclosure Complaint
The single most common complaint across review platforms is that patients see an advertised medication price but aren't clear upfront that a separate membership fee (commonly $39 for the first month, then $149/month) is layered on top. This means a patient expecting to pay one number often receives a bill roughly double what they anticipated once both charges are combined.
Cancellation and Refund Complaints
A recurring theme across BBB and consumer review platforms involves difficulty obtaining refunds, particularly for orders cancelled shortly after purchase but before shipment, and confusion around cancellation timing requirements. Patients have also reported charges continuing after they believed a cancellation was processed. If you enroll with Hims or any subscription-based provider, save written confirmation of any cancellation and monitor your statement for several billing cycles afterward.
Separately from billing complaints, Hims faced significant regulatory scrutiny: the FDA issued a warning letter in September 2025 citing misleading marketing claims about compounded semaglutide, and the agency sent over 55 warning letters industry-wide to online GLP-1 sellers that same month. In early 2026, Novo Nordisk sued Hims over a low-cost compounded semaglutide pill; Hims withdrew the product, and the companies reached a settlement making Hims an authorized distributor of Novo Nordisk's branded products instead. This reflects the same broader industry-wide compounding regulatory shift discussed elsewhere — not a claim specific to ongoing service quality.
What to Verify With Any Provider After Reading Complaints Like These
Before enrolling anywhere: ask directly whether there's a separate membership fee beyond the advertised medication price, read the cancellation and refund policy in full rather than assuming, and confirm which specific medication (compounded or brand) is currently being offered, given how much the regulatory landscape has shifted since 2025.
What to Prioritize Instead
- Is there a separate membership fee on top of the advertised medication price?
- What's the exact refund policy for orders cancelled before shipment?
- Is the medication currently compounded or brand-name, and has that changed recently?
- One flat, all-inclusive price disclosed upfront
- A clear, simple cancellation process
- Transparency about pharmacy licensing and medication sourcing
One price.
No surprises at checkout.
Compounded semaglutide at $197/month or tirzepatide at $297/month — medical evaluation, provider visits, and shipping all included in that one number.
Get Started → Or start your free health assessmentFrequently Asked Questions
That the advertised medication price doesn't clearly disclose a separate membership fee (commonly $39 first month, then $149/month), leading to bills higher than patients expected.
Yes. The FDA issued a warning letter in September 2025 over compounded semaglutide marketing claims, part of a broader industry-wide enforcement action against dozens of online GLP-1 sellers that month.
Following a lawsuit from Novo Nordisk and a subsequent settlement, Hims withdrew its low-cost compounded semaglutide pill and became an authorized distributor of Novo Nordisk's branded products instead.
Multiple consumer complaints describe difficulty obtaining refunds, particularly for orders cancelled before shipment. Confirm the specific refund policy directly and save all cancellation confirmations.
Ask directly whether the advertised price is the total cost or whether a separate membership or consultation fee applies on top of it, before enrolling.
No. Luma Health's $197/month semaglutide and $297/month tirzepatide are single, all-inclusive prices with no separate membership fee added on top.
References
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA.gov. 2025. FDA.gov
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov
- Better Business Bureau. Hims & Hers Inc. complaint profile. BBB.org. 2026. BBB.org
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567185